BOLT Bolt Biotherapeutics, Inc.
Bolt Biotherapeutics, Inc. (BOLT) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 0% planned / 100% discretionary
Largest single sale: $29.6K.
Where they traded
Last open-market purchase: June 5, 2026 , by Quinn William P. .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Quinn William P. | President, CEO and CFO | Sell | 9,132 | $3.24 | $29.6K | 25,384 −26.5% of holding | |
| Yonehiro Grant | Chief Operating Officer | Sell | 6,850 | $3.24 | $22.2K | 17,269 −28.4% of holding | |
| Nemec Sarah | Senior VP, Finance and PAO | Sell | 4,077 | $3.24 | $13.2K | 17,082 −19.3% of holding | |
| Quinn William P. | President, CEO and CFO | Sell | 6,545 | $3.32 | $21.7K | 34,516 −15.9% of holding | |
| Yonehiro Grant | Chief Operating Officer | Sell | 4,909 | $3.32 | $16.3K | 24,119 −16.9% of holding | |
| Nemec Sarah | Senior VP, Finance and PAO | Sell | 2,922 | $3.32 | $9.7K | 21,159 −12.1% of holding | |
| Quinn William P. | President, CEO and CFO | Sell | 1,889 | $3.77 | $7.1K | 41,061 −4.4% of holding | |
| Yonehiro Grant | Chief Operating Officer | Sell | 1,417 | $3.77 | $5.3K | 29,028 −4.7% of holding | |
| Nemec Sarah | Senior VP, Finance and PAO | Sell | 843 | $3.77 | $3.2K | 24,081 −3.4% of holding | |
| Quinn William P. | President, CEO and CFO | Buy | 637 | $3.88 | $2.5K | 2,950 | |
| Nemec Sarah | Senior VP, Finance and PAO | Buy | 509 | $3.88 | $2.0K | 1,924 | |
| Quinn William P. | President, CEO and CFO | Buy | 125 | $4.61 | $576 | 2,313 | |
| Nemec Sarah | Senior VP, Finance and PAO | Buy | 125 | $4.61 | $576 | 1,415 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.